A carregar...
Enzalutamide: targeting the androgen signalling pathway in metastatic castration‐resistant prostate cancer
Significant progress has been made in the understanding of the underlying cancer biology of castration‐resistant prostate cancer (CRPC) with the androgen receptor (AR) signalling pathway remaining implicated throughout the prostate cancer disease continuum. Reactivation of the AR signalling pathway...
Na minha lista:
| Publicado no: | BJU Int |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744713/ https://ncbi.nlm.nih.gov/pubmed/25818596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.13123 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|